Clinical trials
Recruiting Multiple Myeloma trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 7 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Myeloma Network B.V. | 3 |
| Oslo University Hospital | 3 |
| AbbVie | 2 |
| Janssen Research & Development, LLC | 2 |
| Pfizer | 2 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| GlaxoSmithKline | 1 |
| Ichnos Sciences SA | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 22 |
| Immunoglobulin Light-chain Amyloidosis | 1 |
| Infections | 1 |
| Leukemia, Plasma Cell | 1 |
| Neoplasms | 1 |
| Neoplasms, Plasma Cell | 1 |
| Recurrence | 1 |
| Smoldering Multiple Myeloma | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.